Proto-Oncogene Protein c-ets-1
"Proto-Oncogene Protein c-ets-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ets proto-oncogene protein expressed primarily in adult LYMPHOID TISSUE; BRAIN; and VASCULAR ENDOTHELIAL CELLS.
| Descriptor ID |
D050784
|
| MeSH Number(s) |
D12.776.260.665.100 D12.776.624.664.700.175.100 D12.776.930.720.100
|
| Concept/Terms |
Proto-Oncogene Protein c-ets-1- Proto-Oncogene Protein c-ets-1
- Proto Oncogene Protein c ets 1
- c-ets-1, Proto-Oncogene Protein
- c-ets-1 Protein
- c ets 1 Protein
- Proto-Oncogene Protein ets-1
- Proto Oncogene Protein ets 1
- ets-1, Proto-Oncogene Protein
- Proto-Oncogene Proteins c-ets-1
- Proto Oncogene Proteins c ets 1
- c-ets-1, Proto-Oncogene Proteins
- Ets-1 Transcription Factor
- Ets 1 Transcription Factor
- Transcription Factor, Ets-1
- c-ets1 Transcription Factor
- Transcription Factor, c-ets1
- c ets1 Transcription Factor
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Protein c-ets-1".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Protein c-ets-1".
This graph shows the total number of publications written about "Proto-Oncogene Protein c-ets-1" by people in this website by year, and whether "Proto-Oncogene Protein c-ets-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 1 | 2 |
| 2014 | 1 | 2 | 3 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Protein c-ets-1" by people in Profiles.
-
REST promotes ETS1-dependent vascular growth in medulloblastoma. Mol Oncol. 2021 05; 15(5):1486-1506.
-
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis. EBioMedicine. 2019 Feb; 40:290-304.
-
Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells. PLoS One. 2016; 11(3):e0150450.
-
STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13. Nat Commun. 2014 Dec 15; 5:5798.
-
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun. 2014 Oct 29; 5:5202.
-
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014 Aug 11; 26(2):222-34.
-
Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proc Natl Acad Sci U S A. 2013 Apr 09; 110(15):6091-6.
-
Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proc Natl Acad Sci U S A. 2011 Jan 11; 108(2):626-31.
-
Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators. J Cell Sci. 2010 Oct 15; 123(Pt 20):3566-75.
-
DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma. Int J Cancer. 2009 Jun 15; 124(12):2837-44.